Back
Speaker illustration

Doctor Gerald Chi

Harvard Medical School, Boston (United States of America)

Dr Chi is a clinical research staff scientist at Beth Israel Deaconess Medical Center and instructor in medicine at Harvard Medical School. Dr. Chi has served as an investigator in clinical studies focusing on coronary artery disease, atrial fibrillation, stroke, venous thromboembolism, and dyslipidemia.

Presentations

Association of low hemoglobin with venous thromboembolism in acutely ill hospitalized medical patients: findings from the APEX trial

Event: ESC Congress 2018

Topic: Venous Thromboembolism

Session: Thromboembolism and hypertension in the pulmonary circulation

Access
Like
Thumbnail

Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from the PIONEER AF-PCI trial

Event: ESC Congress 2017

Topic: PCI: long-term outcome

Session: Determinants of long-term post-PCI outcomes

Access
Like
Thumbnail

Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis

Event: ESC Congress 2017

Topic: Thrombosis and coagulation

Session: Latest on STEMI

Access
Like
Thumbnail

N-terminal pro-B-type natriuretic peptide (NT-proBNP) is associated with stroke among hospitalized medical patients: an APEX trial substudy.

Event: ESC Congress 2017

Topic: Stroke

Session: Stroke and Carotid disease

Access
Like
Thumbnail

Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy

Event: ESC Congress 2017

Topic: Thrombosis and coagulation

Session: Coronary artery disease: from bench to bedside

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources